Instructions for Dr. Mom strawberry-flavored lollipops strip No. 20
Composition
active ingredients: dry extract of licorice, dry extract of ginger, dry extract of emblica, menthol;
1 lollipop contains: dry extract of licorice (Glycyrrhiza glabra) (5:1) (extractant: purified water) 3.0 mg; dry extract of ginger (Zingiber officinale) (10:1) (extractant: purified water) 1.0 mg; dry extract of emblica officinalis (Emblica officinalis) (4:1) (extractant: purified water) 2.5 mg; menthol 7.0 mg;
excipients: excipients: sucrose, glucose solution, glycerin, citric acid monohydrate, strawberry flavoring, Ponceau 4R dye (E 124).
Dosage form
Lollipops.
Main physicochemical properties: round biconvex candies from red to cherry-red in color with strawberry flavor.
Pharmacotherapeutic group
Means for use in coughs and colds. ATX code R05X.
Pharmacological properties
A combined drug with expectorant and anti-inflammatory effects.
The pharmacological properties of the drug are due to the components that make up its composition.
Licorice extract (Glycyrrhiza glabra L.) has anti-inflammatory, antispasmodic and expectorant effects. Ginger extract (Zingiber officinalis Rosc.) has anti-inflammatory and analgesic effects. Emblica extract (Emblica officinalis Gaetn.) has anti-inflammatory and antipyretic effects. Menthol has antispasmodic and antiseptic effects.
Indication
Symptomatic therapy of acute and chronic diseases of the upper respiratory tract accompanied by cough (pharyngitis, laryngitis, including "lecturer" laryngitis, tracheitis, bronchitis).
Contraindication
Hypersensitivity to any of the components of the drug;
liver and kidney dysfunction;
diseases accompanied by disorders of bile secretion (cholelithiasis and bile duct obstruction);
arterial hypertension;
hypokalemia;
severe obesity;
spasmophilia;
bronchial asthma;
diabetes;
childhood.
Interaction with other medicinal products and other types of interactions
Dr. Mom®, lozenges, should not be used simultaneously with antitussives and drugs that suppress sputum formation, as this prevents expectoration of thinned sputum.
Hypokalemia (as a result of excessive use of licorice root) may be exacerbated by interaction with cardiac glycosides, antiarrhythmic drugs and drugs that affect the heart rhythm (e.g. quinidine). When used together with drugs that cause the development of hypokalemia (thiazide and loop diuretics, adrenocorticosteroids and laxatives), electrolyte imbalance may occur, so the drug should not be used for a long time simultaneously with the above drugs.
May increase the absorption of sulfaguanidine.
Caution is required when used concomitantly with warfarin due to the possibility of bleeding due to increased INR (international normalized ratio).
Application features
If symptoms of the disease persist for more than 2 days and are accompanied by headache, nausea, or vomiting, you should consult a doctor.
Patients with gastroesophageal reflux (heartburn) should avoid using the drug as heartburn may increase.
Lollipops can be a choking hazard.
Use with caution in individuals with aspiration and swallowing problems.
Keep out of reach of children.
Important information about excipients
This medicinal product contains 1.62 g sucrose and 0.88 g glucose per dose. Use with caution in patients with diabetes mellitus. As the medicinal product contains glucose and sucrose, patients with hereditary fructose intolerance, glucose/galactose malabsorption syndrome and sucrase/isomaltase deficiency should not take this medicinal product. May be harmful to teeth.
This medicine contains the dye Ponceau 4R (E 124), which may cause allergic reactions.
Use during pregnancy or breastfeeding
The drug is contraindicated for use during pregnancy. If it is necessary to take the drug during treatment, breastfeeding should be discontinued.
Ability to influence reaction speed when driving vehicles or other mechanisms
The use of the drug in the specified dose does not affect the ability to drive vehicles or work with potentially dangerous mechanisms.
Method of administration and doses
Adults should take 1 lollipop every 2 hours (dissolve slowly).
The maximum daily dose is 10 lollipops.
Duration of treatment is no more than 3 days without consulting a doctor.
Children
It is not recommended to prescribe under 18 years of age.
Overdose
Prolonged (more than 4 weeks) and/or excessive use of licorice preparations may lead to water retention, hypokalemia, hypertension; in some cases, hypokalemic myopathy and myoglobinuria are possible. There may be pain in the heart area, cardiac arrhythmias, hypertensive encephalopathy, and occasionally, damage to the gastric mucosa.
In case of overdose, symptomatic treatment is carried out.
Side effects
Allergic reactions, including rashes, including vesicular, papular, itching, skin hyperemia, urticaria, angioedema.
Possible side effects: water and electrolyte imbalance (edema), increased blood pressure, pain in the heart area, heart rhythm disturbances (with simultaneous use of several drugs containing licorice), dermatitis, dizziness.
Adverse reaction reporting
Reporting adverse reactions after the registration of a medicinal product is important. This allows monitoring of the benefit/risk ratio of the medicinal product. Medical and pharmaceutical professionals, as well as patients or their legal representatives, should report all cases of suspected adverse reactions and lack of efficacy of the medicinal product via the automated pharmacovigilance information system at the following link: https://aisf.dec.gov.ua.
Expiration date
3 years.
Storage conditions
Store at a temperature not exceeding 30 °C in the original packaging, out of the reach of children.
Packaging
4 lollipops in a strip, 5 strips in a cardboard box.
Vacation category
Without a prescription.
Producer
Unique Pharmaceutical Laboratories (a division of J.B. Chemicals and Pharmaceuticals Ltd.).
Location of the manufacturer and address of its place of business.
Plot No. 101/2 and 102/1, Daman Industrial Estate, Airport Road, Village Kadaya, Daman – 396 210, India.
Applicant
Johnson & Johnson Ukraine LLC, Ukraine.
Location of the applicant.
01010, Kyiv, Ostrozkyh Knyaziv Street, building 32/2.
+38 (044) 498 0888
+38 (044) 498 7392
